Pfizer Could Launch US Bevacizumab This Year Despite Patent Thicket

 
• By Aidan Fry
  
2019
Pfizer recently said it planned to launch biosimilar bevacizumab in the US this year, but several patents stand in the way • Source: Shutterstock

More from Biosimilars

More from Products